Vaccine adjuvant discovery program
Award Notice Posted
- Solicitation number
- BAA-DAIT-75N93022R00022
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to University Of Montana
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93024C00024 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Missoula, Montana 59812, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a cost-reimbursement contract worth $10,172,188 to the University of Montana on September 19, 2024 for the Vaccine Adjuvant Discovery Program. The contract, which is not fixed-priced, was awarded under contract number 75N93024C00024 and involves the provision of goods and services related to vaccine adjuvant discovery.
Notice text
This is not fixed-priced. This is a cost-reimbursement contract.
Awarded contract 75N93024C00024 to UNIVERSITY OF MONTANA for 10172188.00 on 2024-09-19.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Vaccine adjuvant discovery program | Award Notice | |
| Vaccine adjuvant discovery program | Award Notice | |
| Vaccine adjuvant discovery program | Award Notice | |
| Vaccine adjuvant discovery program | Solicitation | |
| Vaccine adjuvant discovery program | Pre-Solicitation |
6 of 7 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity